- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00762385
Clinical Comparison of Two Silicone-Hydrogel Contact Lenses
June 18, 2018 updated by: Johnson & Johnson Vision Care, Inc.
The objective of this study is to evaluate the clinical performance of two silicone-hydrogel contact lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
97
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The subject must be at least 18 and less than or equal to 39 years of age and have a need for vision correction in both eyes.
- The subject must require a lens power between -1.00 to -6.00D and have no more than 1.00D of corneal cylinder.
- The subject, based on his/her knowledge, must be in good general health.
- The subject must be able and willing to adhere to the instructions set forth in this protocol and complete all specified evaluations.
- Subject must be a current adapted daily wearer of soft contact lenses with at least 6 months of CL wear.
- Subject must agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
- Subject must be willing and able to use only the care systems and lubricating drops provided for the study during the 4 week period.
- The subject must read, indicate understanding of and sign the Informed Consent Form.
Exclusion Criteria:
- The subject is a rigid gas permeable (RGP) or daily disposable lens wearer.
- The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids or associated structures.
- The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjogren's syndrome, type II diabetes, etc.)
Slit lamp findings that would contraindicate contact lens wear such as:
- pathological dry eye or associated findings
- pterygium or corneal scars within the visual axis
- neovascularization equal to or greater than 1mm in from the limbus
- history of giant papillary conjunctivitis (GPC) worse than grade 2
- anterior uveitis or iritis (past or present)
- seborrhoeic eczema
- seborrhoeic conjunctivitis
- A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
- A known history of corneal hypoesthesia (reduced corneal sensitivity).
- Contact lens snellen visual acuities (VA) worse than 20/30.
- Aphakia, keratoconus or a highly irregular cornea.
- Current pregnancy or lactation (to the best of the subject's knowledge)
- Any active participation in another clinical study at any time during this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: galyfilcon A/comfilcon A
galyfilcon A first, comfilcon A second
|
galyfilcon A
comfilcon A
|
Active Comparator: comfilcon A/galyfilcon A
comfilcon A first, galyfilcon A second
|
galyfilcon A
comfilcon A
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lens Comfort
Time Frame: 1-week, 2- weeks
|
>0 = comfortable, <0 = uncomfortable; a weighted combined score calculated from individual comfort-related questions was used to derive comfort outcomes.
|
1-week, 2- weeks
|
Comfort Symptoms
Time Frame: 1-week, 2-weeks
|
A weighted combined score calculated from individual comfort-related questions was used to derive comfort outcomes.
>0 = comfortable, <0 = uncomfortable
|
1-week, 2-weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall Corneal Staining
Time Frame: 2 weeks
|
Measured for 5 zones of the cornea (superior, nasal, central, inferior, temporal)on a 0 to 3 grade scale (NEI 0-3 scale).
Grade 0 = Normal/ grade 1 = mild, superficial stippling/ grade 2 = moderate, punctate staining including superficial abrasion of the cornea/ grade 3 = severe, abrasion or corneal erosion, deep corneal abrasion or recurrent erosion.
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2007
Primary Completion (Actual)
October 1, 2007
Study Completion (Actual)
October 1, 2007
Study Registration Dates
First Submitted
September 29, 2008
First Submitted That Met QC Criteria
September 29, 2008
First Posted (Estimate)
September 30, 2008
Study Record Updates
Last Update Posted (Actual)
June 19, 2018
Last Update Submitted That Met QC Criteria
June 18, 2018
Last Verified
May 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR-0713
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Error
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
Tianjin Eye HospitalRecruitingMyopia; Refractive ErrorChina
-
Abbott Medical OpticsCompletedStable Myopic Refractive Error, With or Without AstigmatismUnited States
-
KK Women's and Children's HospitalWithdrawnRefractive Error - Myopia
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
Clinical Trials on galyfilcon A
-
Johnson & Johnson Vision Care, Inc.Coles-Brennan Pty LtdCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
CIBA VISIONUniversity of WaterlooCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedMyopiaUnited States
-
Coopervision, Inc.CompletedAmetropiaUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedMyopiaUnited States
-
Johnson & Johnson Vision Care, Inc.Completed